Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Dual Antiplatelet Therapy in the Prevention of Recurrent Ischemic Events.

Domanski MJ.

J Am Coll Cardiol. 2016 Jun 14;67(23):2741-3. doi: 10.1016/j.jacc.2016.04.019. No abstract available.

PMID:
27282894
2.

Next Steps in Primary Prevention of Coronary Heart Disease: Rationale for and Design of the ECAD Trial.

Domanski MJ, Fuster V, Diaz-Mitoma F, Grundy S, Lloyd-Jones D, Mamdani M, Roberts R, Thorpe K, Hall J, Udell JA, Farkouh ME.

J Am Coll Cardiol. 2015 Oct 20;66(16):1828-36. doi: 10.1016/j.jacc.2015.08.857. Review.

3.

Predictors of stroke associated with coronary artery bypass grafting in patients with diabetes mellitus and multivessel coronary artery disease.

Domanski MJ, Farkouh ME, Zak V, Feske S, Easton D, Weinberger J, Hamon M, Escobedo J, Shrader P, Siami FS, Fuster V.

Am J Cardiol. 2015 May 15;115(10):1382-8. doi: 10.1016/j.amjcard.2015.02.033.

PMID:
25824543
4.

Left ventricular assist devices improve functional class without normalizing peak oxygen consumption.

Benton CR, Sayer G, Nair AP, Ashley K, Domanski MJ, Henzlova MJ, Anyanwu AC, Pinney SP.

ASAIO J. 2015 May-Jun;61(3):237-43. doi: 10.1097/MAT.0000000000000199.

PMID:
25635934
5.

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.

Zannad F, Garcia AA, Anker SD, Armstrong PW, Calvo G, Cleland JG, Cohn JN, Dickstein K, Domanski MJ, Ekman I, Filippatos GS, Gheorghiade M, Hernandez AF, Jaarsma T, Koglin J, Konstam M, Kupfer S, Maggioni AP, Mebazaa A, Metra M, Nowack C, Pieske B, Piña IL, Pocock SJ, Ponikowski P, Rosano G, Ruilope LM, Ruschitzka F, Severin T, Solomon S, Stein K, Stockbridge NL, Stough WG, Swedberg K, Tavazzi L, Voors AA, Wasserman SM, Woehrle H, Zalewski A, McMurray JJ.

Eur J Heart Fail. 2013 Oct;15(10):1082-94. doi: 10.1093/eurjhf/hft095.

6.

Optimization of pulsatile flow for mechanical circulatory support.

Domanski MJ, Giddens DP.

J Heart Lung Transplant. 2013 Jun;32(6):577-8. doi: 10.1016/j.healun.2013.03.013. No abstract available.

PMID:
23701849
7.

Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.

Omland T, Pfeffer MA, Solomon SD, de Lemos JA, Røsjø H, Šaltytė Benth J, Maggioni A, Domanski MJ, Rouleau JL, Sabatine MS, Braunwald E; PEACE Investigators..

J Am Coll Cardiol. 2013 Mar 26;61(12):1240-9. doi: 10.1016/j.jacc.2012.12.026. Erratum in: J Am Coll Cardiol. 2014 Jan 21;63(2):195-200.

9.

Prognostic implications of troponin T and creatine kinase-MB elevation after coronary artery bypass grafting.

Domanski MJ.

Am Heart J. 2012 Nov;164(5):636-7. doi: 10.1016/j.ahj.2012.07.018. No abstract available.

PMID:
23137492
10.

Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions.

Fleg JL, Stone GW, Fayad ZA, Granada JF, Hatsukami TS, Kolodgie FD, Ohayon J, Pettigrew R, Sabatine MS, Tearney GJ, Waxman S, Domanski MJ, Srinivas PR, Narula J.

JACC Cardiovasc Imaging. 2012 Sep;5(9):941-55. doi: 10.1016/j.jcmg.2012.07.007. Review.

11.

Hypothesis: Catheter-based renal sympathetic denervation should be the initial therapy for essential hypertension.

Lakhanpal JR, Domanski MJ.

Med Hypotheses. 2012 Apr;78(4):482-4. doi: 10.1016/j.mehy.2012.01.011.

PMID:
22289343
12.

Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery.

Domanski MJ, Mahaffey K, Hasselblad V, Brener SJ, Smith PK, Hillis G, Engoren M, Alexander JH, Levy JH, Chaitman BR, Broderick S, Mack MJ, Pieper KS, Farkouh ME.

JAMA. 2011 Feb 9;305(6):585-91. doi: 10.1001/jama.2011.99.

PMID:
21304084
13.

A sensitive cardiac troponin T assay in stable coronary artery disease.

Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, Pfeffer MA, Braunwald E; Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators..

N Engl J Med. 2009 Dec 24;361(26):2538-47. doi: 10.1056/NEJMoa0805299.

14.

Home use of automated external defibrillators for sudden cardiac arrest.

Bardy GH, Lee KL, Mark DB, Poole JE, Toff WD, Tonkin AM, Smith W, Dorian P, Packer DL, White RD, Longstreth WT Jr, Anderson J, Johnson G, Bischoff E, Yallop JJ, McNulty S, Ray LD, Clapp-Channing NE, Rosenberg Y, Schron EB; HAT Investigators..

N Engl J Med. 2008 Apr 24;358(17):1793-804. doi: 10.1056/NEJMoa0801651.

15.

Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function.

Hsia J, Jablonski KA, Rice MM, Sabatine MS, Zabalgoitia M, Maggioni A, Cuddy TE, Domanski MJ, Geller NL, Flaker G, Solomon S, Omland T, Rouleau JL; PEACE Investigators..

Am J Cardiol. 2008 Feb 15;101(4):457-61. doi: 10.1016/j.amjcard.2007.09.107.

PMID:
18312757
16.

Primary prevention of coronary artery disease.

Domanski MJ.

N Engl J Med. 2007 Oct 11;357(15):1543-5. No abstract available.

PMID:
17928603
17.

Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.

Sabatine MS, Morrow DA, O'Donoghue M, Jablonksi KA, Rice MM, Solomon S, Rosenberg Y, Domanski MJ, Hsia J; PEACE Investigators..

Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2463-9.

18.

Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.

Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E; PEACE Investigators..

J Am Coll Cardiol. 2007 Jul 17;50(3):205-14.

19.

Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Olshansky B, Wood F, Hellkamp AS, Poole JE, Anderson J, Johnson GW, Boineau R, Domanski MJ, Mark DB, Lee KL, Bardy GH; SCD-HeFT Investigators..

Am Heart J. 2007 Jun;153(6):1089-94.

PMID:
17540216
20.

Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy.

Mitchell GF, Dunlap ME, Warnica W, Ducharme A, Arnold JM, Tardif JC, Solomon SD, Domanski MJ, Jablonski KA, Rice MM, Pfeffer MA; Prevention of Events With Angiotensin-Converting Enzyme Inhibition Investigators..

Hypertension. 2007 Jun;49(6):1271-7.

Supplemental Content

Loading ...
Support Center